Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy

참고문헌 (8)

1. Hund E, "Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment", Neurology, 56, pp.431~435 (2001)
2. Benson MD, "Liver transplantation and transthyretin amyloidosis", Muscle Nerve, 47, pp.157~162 (2013)
3. Said G, "Familial amyloid polyneuropathy: a clinico-pathologic study", J Neurol Sci, 284, pp.149~154 (2009)
4. Sekijima Y, "Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis", Neurology, 87, pp.773~781 (2016)
5. Liepnieks JJ, "Progression of transthyretin amyloid neuropathy after liver transplantation", Neurology, 75, pp.324~327 (2010)
6. Coelho T, "Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy", J Neurol, 260, pp.2802~2814 (2013)
7. Sekijima Y, "Transthyretin-type cerebral amyloid angiopathy: a serious complication in post-transplant patients with familial amyloid polyneuropathy", J Neurol Neurosurg Psychiatry, 86, pp.124~ (2015)
8. Benson MD, "Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment", Amyloid, 17, pp.43~49 (2010)

관련 논문AI추천